Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

Purpose: To explore the efficacy and safety of lower-dose decitabine in patients with lower-risk MDS, a prospective multicenter phase II study was conducted to compare decitabine with the best supportive care (BSC). Methods: Patients diagnosed with lower-risk MDS from September 2013 to August 2018 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Li, Mei, Chen, Ren, Yanling, Zhou, Xinping, Ma, Liya, Xu, Weilai, Wei, Juying, Jiang, Huifang, Zhang, Liming, Zeng, Hui, Tong, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040893/
https://www.ncbi.nlm.nih.gov/pubmed/33854598
http://dx.doi.org/10.7150/jca.56207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040893/
https://www.ncbi.nlm.nih.gov/pubmed/33854598
http://dx.doi.org/10.7150/jca.56207

Ejemplares similares